<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">THEOPHYLLINE <img border="0" src="../images/pr.gif"/></span><br/>(thee-off'i-lin)<br/><span class="topboxtradename">Bronkodyl, </span><span class="topboxtradename">Elixophyllin, </span><span class="topboxtradename">Lanophyllin, </span><span class="topboxtradename">PMS Theophylline <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Pulmopylline <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Quibron-T, </span><span class="topboxtradename">Respbid, </span><span class="topboxtradename">Slo-Bid, </span><span class="topboxtradename">Slo-Phyllin, </span><span class="topboxtradename">Theo-Dur, </span><span class="topboxtradename">Theo-24, </span><span class="topboxtradename">Theolair, </span><span class="topboxtradename">Theophylline Ethylenediamine, </span><span class="topboxtradename">Theospan-SR, </span><span class="topboxtradename">Uni-Dur, </span><span class="topboxtradename">Uniphyl<br/></span><b>Classifications:</b> <span class="classification">bronchodilator (respiratory smooth muscle relaxant)</span>; <span class="classification">xanthine</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg, 125 mg, 200 mg, 250 mg, 300 mg tablets; 100 mg, 200 mg capsules; 80 mg/15 mL, 150 mg/15 mL liquid; 100 mg, 200 mg, 250 mg, 300 mg, 450 mg, 500 mg, 600 mg sustained-release tablets; 50 mg, 75 mg, 100 mg, 125 mg, 200 mg, 250 mg, 260 mg, 300 mg sustained-release capsules; 200 mg, 400 mg, 800 mg injection</p>
<h1><a name="action">Actions</a></h1>
<p>Xanthine derivative that relaxes smooth muscle by direct action, particularly of bronchi and pulmonary vessels, and stimulates
         medullary respiratory center with resulting increase in vital capacity. Also relaxes smooth muscles of biliary and GI tracts.
         Stimulates myocardium, thereby increasing force of contractions and cardiac output, and stimulates all levels of CNS, but
         to a lesser degree than caffeine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective for relief of bronchospasm in asthmatics, chronic bronchitis, and emphysema.</p>
<h1><a name="uses">Uses</a></h1>
<p>Prophylaxis and symptomatic relief of bronchial asthma, as well as bronchospasm associated with chronic bronchitis and emphysema.
         Also used for emergency treatment of paroxysmal cardiac dyspnea and edema of CHF.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Treatment of apnea and bradycardia of prematures and to reduce severe bronchospasm associated with cystic fibrosis and acute
         descending respiratory infection. Theophylline sodium glycinate is a mixture of sodium theophylline and aminoacetic (glycine).
         Contains 4547% theophylline. Similar actions, uses, adverse reactions, and precautions as other theophylline derivatives
         but claimed to produce less gastric irritation.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to xanthines; coronary artery disease or angina pectoris when myocardial stimulation might be harmful; severe
         renal or liver impairment. Safety during pregnancy (category C) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Children; compromised cardiac or circulatory function, hypertension; hyperthyroidism; peptic ulcer; prostatic hypertrophy;
         glaucoma; diabetes mellitus; older adults and neonates.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Bronchospasm</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">PO/IV Loading Dose</span> 5 mg/kg<br/><span class="rdage">Adult:</span> <span class="rdroute">PO/IV Maintenance Dose*</span>
<i>Nonsmoker,</i> 0.4 mg/kg/h [*IV by continuous infusion, PO divided q6h (immediate release) or q812h (sustained release)]; <i>Smoker,</i> 0.6 mg/kg/h; <i>with CHF or cirrhosis,</i> 0.2 mg/kg/h<br/><span class="rdage">Child:</span> <span class="rdroute">PO/IV Maintenance Dose*</span>
<i>19 y,</i> 0.8 mg/kg/h; <i>1012 y,</i> 0.6 mg/kg/h<br/><span class="rdage">Infant:</span> <span class="rdroute">PO/IV Maintenance Dose*</span>
<i>26 mo,</i> 0.4 mg/kg/h; <i>611 mo,</i> 0.7 mg/kg/h<br/><span class="rdage">Neonate:</span> <span class="rdroute">PO/IV Maintenance Dose*</span> 0.13 mg/kg/h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<p>
         			Note: All doses based on ideal body weight.
         		
      </p><span class="adminroutetype">Oral</span><br/><ul>
<li>Wait 46 h after the last IV dose, when switching from IV to oral dosing.</li>
<li>Give with a full glass of water and after meals to minimize gastric irritation.</li>
<li>Give sustained-release forms and enteric-coated tablets whole. Chewable tablets must be chewed thoroughly before swallowing.
            Sustained-release granules from capsules can be taken on an empty stomach or mixed with applesauce or water.
         </li>
<li>
            				Note: Timing of dose is critical. Be certain patient understands necessity to adhere to the correct intervals between doses.
            			
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>Give <i>prediluted solutions</i> at a rate not to exceed 20 mg/min.
                  </li>
</ul>
<p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span> Give IV theophylline ethylenediamine solution with a concentration of 25 mg/mL undiluted by direct IV or diluted (preferred)
                  in up to 200 mL of D5W.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">IV Infusion:</span> Give at a rate not to exceed 20 mg/min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>Amikacin,</b>
<b>ascorbic acid,</b>
<b>bleomycin,</b>
<span class="classification">cephalosporins</span>, <b>chlorpromazine,</b>
<b>clindamycin,</b>
<b>codeine phosphate,</b>
<b>dimenhydrinate,</b>
<b>dobutamine,</b>
<b>dopamine,</b>
<b>doxapram,</b>
<b>doxorubicin,</b>
<b>epinephrine,</b>
<b>hydralazine,</b>
<b>hydroxyzine,</b>
<b>insulin,</b>
<b>isoproterenol,</b>
<b>levorphanol,</b>
<b>meperidine,</b>
<b>methadone,</b>
<b>methylprednisolone,</b>
<b>morphine,</b>
<b>nafcillin,</b>
<b>norepinephrine,</b>
<b>oxytetracycline,</b>
<b>papaverine,</b>
<b>penicillin G,</b>
<b>pentazocine,</b>
<b>procaine,</b>
<b>prochlorperazine,</b>
<b>promazine,</b>
<b>promethazine,</b>
<b>tetracycline,</b>
<b>verapamil,</b>
<b>vitamin B complex with C.</b>
<span class="incompattype">Y-site:</span>
<b>Amiodarone,</b>
<b>codeine phosphate,</b>
<b>clindamycin,</b>
<span class="classification">phenothiazines</span>
<b>(chlorpromazine,</b>
<b>prochlorperazine),</b>
<b>epinephrine,</b>
<b>dobutamine,</b>
<b>dopamine,</b>
<b>levorphanol,</b>
<b>meperidine,</b>
<b>methadone,</b>
<b>morphine,</b>
<b>norepinephrine,</b>
<b>phenytoin,</b>
<b>verapamil.</b>
</p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Stimulation (Irritability, restlessness, insomnia, dizziness, headache, tremor, hyperexcitability, muscle twitching, <span class="speceff-life">drug-induced seizures</span>). <span class="typehead">CV:</span> Palpitation, <span class="speceff-common">tachycardia,</span> extrasystoles, flushing, marked hypotension, <span class="speceff-life">circulatory failure</span>. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> vomiting, anorexia, epigastric or abdominal pain, diarrhea, activation of peptic ulcer. <span class="typehead">Urogenital:</span> Transient urinary frequency, albuminuria, kidney irritation. <span class="typehead">Respiratory:</span> Tachypnea, <span class="speceff-life">respiratory arrest</span>. <span class="typehead">Body as a Whole:</span> Fever, dehydration. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>False-positive elevations of <span class="alt">serum uric acid</span> (<span class="alt">Bittner</span> or colorimetric methods). <span class="alt">Probenecid</span> may cause false high <span class="alt">serum theophylline</span> readings, and spectrophotometric methods of determining <span class="alt">serum theophylline</span> are affected by a furosemide, sulfathiazole, phenylbutazone, probenecid, theobromine.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  Increases <b>lithium</b> excretion, lowering lithium levels; <b>cimetidine,</b> high-dose <b>allopurinol</b> (600 mg/d), <b>tacrine,</b>
<span class="classification">quinolones</span>, <span class="classification">macrolide antibiotics</span>, and <b>zileuton</b> can significantly increase theophylline levels; <b>tobacco</b> use significantly decreases levels. <span class="typehead"> Herbal:</span>
<b>St. John's wort</b> may decrease theophylline efficacy. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Most products are 100% absorbed from GI tract. <span class="typehead">Peak:</span> IV 30 min; uncoated tablet 1 h; sustained release 46 h. <span class="typehead">Duration:</span> 48 h; varies with age, smoking, and liver function. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead">Metabolism:</span> Extensively metabolized in liver. <span class="typehead">Elimination:</span> Parent drug and metabolites excreted by kidneys; excreted in breast milk. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor vital signs. Improvement in respiratory status is the expected outcome.</li>
<li>Observe and report early signs of possible toxicity: Anorexia, nausea, vomiting, dizziness, shakiness, restlessness, abdominal
            discomfort, irritability, palpitation, tachycardia, marked hypotension, cardiac arrhythmias, seizures.
         </li>
<li>Monitor for tachycardia, which may be worse in patients with severe cardiac disease. Conversely, theophylline toxicity may
            be masked in patients with tachycardia.
         </li>
<li>Lab tests: Monitor plasma level of theophylline. Be aware that therapeutic plasma level ranges from 1020 mcg/mL (a narrow
            therapeutic range). Levels exceeding 20 mcg/mL are associated with toxicity.
         </li>
<li>Monitor drug levels closely in heavy smokers. Cigarette smoking induces hepatic microsomal enzyme activity, decreasing serum
            half-life and increasing body clearance of theophylline. An increase of dosage from 50100% is usual in heavy smokers.
         </li>
<li>Monitor plasma drug level closely in patients with heart failure, kidney or liver dysfunction, alcoholism, high fever. Plasma
            clearance of xanthines may be reduced.
         </li>
<li>Take necessary safety precautions and forewarn older adult patients of possible dizziness during early therapy.</li>
<li>Monitor patients on sustained release preparations for S&amp;S of overdosage. Continued slow absorption leads to high plasma concentrations
            for a prolonged period.
         </li>
<li>
            							Note: Neonates of mothers using this drug have exhibited slight tachycardia, jitteriness, and apnea.
            						
         </li>
<li>Monitor <b>
<small>CLOSELY</small>
</b> for adverse effects in infants 
      </li></ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medication at the same time every day.</li>
<li>Avoid charcoal-broiled foods (high in polycyclic carbon content); may increase theophylline elimination and reduce the half-life
            as much as 50%.
         </li>
<li>Limit caffeine intake because it may increase incidence of adverse effects.</li>
<li>Cigarette smoking may significantly lower theophylline plasma concentration.</li>
<li>Be aware that a low-carbohydrate, high-protein diet increases theophylline elimination, and a high-carbohydrate, low-protein
            diet decreases it.
         </li>
<li>Drink fluids liberally (20003000 mL/d) if not contraindicated to decrease viscosity of airway secretions.</li>
<li>Avoid self-dosing with OTC medications, especially cough suppressants, which may cause retention of secretions and CNS depression.</li>
<li>Do not breast feed while taking this drug without consulting physician. Since theophylline is distributed into breast milk,
            it may be advisable to nurse the infant just before taking the drug.
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>